Skip to main content
Sailaja Kamaraju, MD, Oncology, West Bend, WI

SailajaKamarajuMD

Oncology West Bend, WI

Assistant Professor, Medicine, Medical College of Wisconsin

Dr. Kamaraju is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kamaraju's full profile

Already have an account?

  • Office

    1110 Oak St
    Alyce Elmore Kraemer Cancer Care Center
    West Bend, WI 53095
    Phone+1 262-334-8484
    Fax+1 414-805-4944

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Hematology and Medical Oncology, 1999 - 2002
  • Hennepin Healthcare
    Hennepin HealthcareResidency, Internal Medicine, 1996 - 1999
  • University of Arizona College of Medicine-Tucson (South Campus)
    University of Arizona College of Medicine-Tucson (South Campus)Internship, Internal Medicine, 1995 - 1996
  • Guntur Medical College NTR
    Guntur Medical College NTRClass of 1993

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2002 - 2025
  • TX State Medical License
    TX State Medical License 2008 - 2015
  • MN State Medical License
    MN State Medical License 1998 - 2005
  • IL State Medical License
    IL State Medical License 2002 - 2002
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Context Therapeutics® to Present Clinical Data on ONA-XR in Breast Cancer at 2021 San Antonio Breast Cancer Symposium
    Context Therapeutics® to Present Clinical Data on ONA-XR in Breast Cancer at 2021 San Antonio Breast Cancer SymposiumNovember 19th, 2021
  • Context Therapeutics and Wisconsin Oncology Network (WON) to Evaluate Apristor Combination Therapy for Women with Advanced Breast Cancer
    Context Therapeutics and Wisconsin Oncology Network (WON) to Evaluate Apristor Combination Therapy for Women with Advanced Breast CancerOctober 7th, 2019

Professional Memberships